Initial supportive evidence for a functional role of IL-23 in psoriasis included the clinical efficacy of an anti-p40 monoclonal antibody (blocking both IL-12 and IL-23) in psoriasis (58) and the association of a single nucleotide polymorphism in the IL23R gene in psoriasis patients (55, 59). This evidence concerns the gene IL23R and psoriasis.